Hypercalcemia associated with neoplastic disease
Muggia, F.M.; Heinemann, H.O.
Annals of Internal Medicine 73(2): 281-290
1970
ISSN/ISBN: 0003-4819 PMID: 5454265 Document Number: 28081
Document emailed within 1 workday
Related Documents
DeConti, R.C. 1971: Correctable complications of neoplastic disease. I. Hypercalcemia Connecticut Medicine 35(4): 275-276Frenning, D.H. 1979: Hypercalcemia in neoplastic diseases Minnesota Medicine 62(7): 541-543
Vezyraki, P.; Vlachaki, A.; Baltogiannis, D.; Batistatou, A.; Tsampalas, S.; V Simos, Y.; Kaltsas, A.; Pappas, P.; Dounousi, E.; Ragos, V.; Tsiambas, E.; Peschos, D. 2019: Impact of total PSA and percent free PSA in the differentiation of prostate disease: a retrospective comparative study implicating neoplastic and non-neoplastic entities Journal of BUON: Official Journal of the Balkan Union of Oncology 24(5): 2107-2113
De la Piedra, C.; Rapado, A.; Esbrit, P. 1985: Serum levels of osteocalcin in hypercalcemia caused by primary hyperparathyroidism and in tumor hypercalcemia Revista Clinica Espanola 177(7): 310-313
Van Steensel-Moll, H.A.; Drop, S.L. 1986: Hypercalcemia in childhood. a boy with asymptomatic hypocalciuric hypercalcemia Tijdschrift Voor Kindergeneeskunde 54(5): 147-150
Eisinger, J.; D'Omezon, Y.; Recordier, A.M. 1973: Mithramycin in the treatment of hypercalcemia and Paget's disease Revue du Rhumatisme et des Maladies Osteo-Articulaires 40(6): 457-460
1984: Absence of parathyroid hormone messenger RNA in malignant disease with hypercalcemia New England Journal of Medicine 310(5): 323-324
McKee, R.L.; Caulfield, M.P. 1989: Synthetic peptides as tools for investigating the pathogenicity of disease: humoral hypercalcemia of malignancy Peptide Research 2(2): 161-166
Schaefer, O.; Hildes, J.A. 1975: Neoplastic disease in Eskimos Canadian Medical Association Journal 113(6): 493-495
Schaefer, O.; Hildes, J.A. 1975: Neoplastic disease in Eskimos Canadian Medical Association Journal 113(6): 493-495
Mazanowska, O.; Klinger, M. 2005: Glomerulonephritis in neoplastic disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(110): 211-214
Rossi, L.; Bombardieri, G.; Bevilacqua, E.; Innocenti, P. 1980: Clinical significance of diamine oxidase (DAO) in serous effusions of neoplastic and non neoplastic origin Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 16(4): 412-418
Araya, J.C.; Roa, J.C.; Villaseca, M.A.; Roa, I.án.; Guzmán, P.; Alvarado, C.és.; Melo, A.él. 2003: Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach Revista Medica de Chile 131(4): 359-365
Evans, V.J.; Price, F.M.; Kerr, H.A.; De Oca, H.M. 1970: Effect of 7,12-dimethylbenz(a)anthracene on non-neoplastic and neoplastic rodent cells in culture Journal of the National Cancer Institute 45(3): 429-441
Bershadskiĭ, A.D. 1984: Changes in the actin cytoskeleton and cell adhesion during processes of neoplastic transformation and normalization of neoplastic cells Vestnik Akademii Meditsinskikh Nauk SSSR 1984(5): 20-25
Jarema, A.; Jarema, M. 1976: Informing the patient about his neoplastic disease Polski Tygodnik Lekarski 31(41): 1775-1777
Micu, G.; Stăniceanu, F.; Zurac, S.; Bastian, A.; Gramadă, E.; Popp, C.; Andrei, R.; Tudorică, L.; Slavnea, A.; Olariu, M.; Tebeică, T.; Ene, A.; Mateescu, R.; Rimbaş, M.; Voiosu, R. 2010: E-cadherin and beta-catenin expression in gastric neoplastic and non-neoplastic lesions--correlations with H. pylori infection Romanian Journal of Internal Medicine 48(3): 271-280
Anderson, J.T.; Thompson, R.C.; McMahon, J.E.; Bradford, D.S. 1977: Total hip replacement in disseminated neoplastic disease Surgery Gynecology and Obstetrics 144(4): 560-562
Paliszewska, L.; Hebanowski, M.; Szelezyński, K. 1977: 2 cases of nephrotic syndrome in the course of neoplastic disease Polski Tygodnik Lekarski 32(35): 1367-1368
Morales Murillo, S.; Melgarejo Moreno, P.; Balil Gilart, A.; Rubio Caballero, M. 1992: Cardiac tamponade as the first manifestation of neoplastic disease Revista Clinica Espanola 191(1): 52-53